The present invention generally relates to tissue fixation devices and fastener assemblies which may be used, for example, for treating gastroesophageal reflux disease. The present invention more particularly relates to such tissue fixation assemblies which may deploy a fastener for fixing tissue with but a single translational movement of a fastener and a stylet.
Gastroesophageal reflux disease (GERD) is a chronic condition caused by the failure of the anti-reflux barrier located at the gastroesophageal junction to keep the contents of the stomach from splashing into the esophagus. The splashing is known as gastroesophageal reflux. The stomach acid is designed to digest meat, and will digest esophageal tissue when persistently splashed into the esophagus.
A principal reason for regurgitation associated with GERD is the mechanical failure of a deteriorated gastroesophageal flap to close and seal against high pressure in the stomach. Due to reasons including lifestyle, a Grade I normal gastroesophageal flap may deteriorate into a malfunctioning Grade III or absent valve Grade IV gastroesophageal flap. With a deteriorated gastroesophageal flap, the stomach contents are more likely to be regurgitated into the esophagus, the mouth, and even the lungs. The regurgitation is referred to as “heartburn” because the most common symptom is a burning discomfort in the chest under the breastbone. Burning discomfort in the chest and regurgitation (burping up) of sour-tasting gastric juice into the mouth are classic symptoms of gastroesophageal reflux disease (GERD). When stomach acid is regurgitated into the esophagus, it is usually cleared quickly by esophageal contractions. Heartburn (backwashing of stomach acid and bile onto the esophagus) results when stomach acid is frequently regurgitated into the esophagus and the esophageal wall is inflamed.
Complications develop for some people who have GERD. Esophagitis (inflammation of the esophagus) with erosions and ulcerations (breaks in the lining of the esophagus) can occur from repeated and prolonged acid exposure. If these breaks are deep, bleeding or scarring of the esophagus with formation of a stricture (narrowing of the esophagus) can occur. If the esophagus narrows significantly, then food sticks in the esophagus and the symptom is known as dysphagia. GERD has been shown to be one of the most important risk factors for the development of esophageal adenocarcinoma. In a subset of people who have severe GERD, if acid exposure continues, the injured squamous lining is replaced by a precancerous lining (called Barrett's Esophagus) in which a cancerous esophageal adenocarcinoma can develop.
Other complications of GERD may not appear to be related to esophageal disease at all. Some people with GERD may develop recurrent pneumonia (lung infection), asthma (wheezing), or a chronic cough from acid backing up into the esophagus and all the way up through the upper esophageal sphincter into the lungs. In many instances, this occurs at night, while the person is in a supine position and sleeping. Occasionally, a person with severe GERD will be awakened from sleep with a choking sensation. Hoarseness can also occur due to acid reaching the vocal cords, causing a chronic inflammation or injury.
GERD never improves without intervention. Life style changes combined with both medical and surgical treatments exist for GERD. Medical therapies include antacids and proton pump inhibitors. However, the medical therapies only mask the reflux. Patients still get reflux and perhaps emphysema because of particles refluxed into the lungs. Barrett's esophagus results in about 10% of the GERD cases. The esophageal epithelium changes into tissue that tends to become cancerous from repeated acid washing despite the medication.
Several open laparotomy and laproscopic surgical procedures are available for treating GERD. One surgical approach is the Nissen fundoplication. The Nissen approach typically involves a 360-degree wrap of the fundus around the gastroesophageal junction. The procedure has a high incidence of postoperative complications. The Nissen approach creates a 360-degree moveable flap without a fixed portion. Hence, Nissen does not restore the normal movable flap. The patient cannot burp because the fundus was used to make the repair, and may frequently experience dysphagia. Another surgical approach to treating GERD is the Belsey Mark IV (Belsey) fundoplication. The Belsey procedure involves creating a valve by suturing a portion of the stomach to an anterior surface of the esophagus. It reduces some of the postoperative complications encountered with the Nissen fundoplication, but still does not restore the normal movable flap. None of these procedures fully restores the normal anatomical anatomy or produces a normally functioning gastroesophageal junction. Another surgical approach is the Hill repair. In the Hill repair, the gastroesophageal junction is anchored to the posterior abdominal areas, and a 180-degree valve is created by a system of sutures. The Hill procedure restores the moveable flap, the cardiac notch and the Angle of His. However, all of these surgical procedures are very invasive, regardless of whether done as a laproscopic or an open procedure.
New, less surgically invasive approaches to treating GERD involve transoral endoscopic procedures. One procedure contemplates a machine device with robotic arms that is inserted transorally into the stomach. While observing through an endoscope, an endoscopist guides the machine within the stomach to engage a portion of the fundus with a corkscrew-like device on one arm. The arm then pulls on the engaged portion to create a fold of tissue or radial plication at the gastroesophageal junction. Another arm of the machine pinches the excess tissue together and fastens the excess tissue with one pre-tied implant. This procedure does not restore normal anatomy. The fold created does not have anything in common with a valve. In fact, the direction of the radial fold prevents the fold or plication from acting as a flap of a valve.
Another transoral procedure contemplates making a fold of fundus tissue near the deteriorated gastroesophageal flap to recreate the lower esophageal sphincter (LES). The procedure requires placing multiple U-shaped tissue clips around the folded fundus to hold it in shape and in place.
This and the previously discussed procedure are both highly dependent on the skill, experience, aggressiveness, and courage of the endoscopist. In addition, these and other procedures may involve esophageal tissue in the repair. Esophageal tissue is fragile and weak, in part due to the fact, that the esophagus is not covered by serosa, a layer of very sturdy, yet very thin tissue, covering and stabilizing all intraabdominal organs, similar like a fascia covering and stabilizing muscle. Involvement of esophageal tissue in the repair of a gastroesophageal flap valve poses unnecessary risks to the patient, such as an increased risk of fistulas between the esophagus and the stomach.
A new and improved apparatus and method for restoration of a gastroesophageal flap valve is fully disclosed in U.S. Pat. No. 6,790,214, issued Sep. 14, 2004, is assigned to the assignee of this invention, and is incorporated herein by reference. That apparatus and method provides a transoral endoscopic gastroesophageal flap valve restoration. A longitudinal member arranged for transoral placement into a stomach carries a tissue shaper that non-invasively grips and shapes stomach tissue. A tissue fixation device is then deployed to maintain the shaped stomach tissue in a shape approximating a gastroesophageal flap.
Whenever tissue is to be maintained in a shape as, for example, with the improved assembly last mentioned above, it is necessary to fasten at least two layers of tissue together. In applications such as gastroesophageal flap valve restoration, there is very limited room to maneuver a fastener deployment device. For example, this and other medical fastening applications provide confined working channels and spaces and often must be fed through an endoscope to permit visualization or other small lumen guide catheters to the place where the fasteners are to be deployed. To make matters worse, multiple fasteners may also be required. Hence, with current fasteners and deployment arrangements, it is often difficult to direct a single fastener to its intended location, let alone a number of such fasteners.
Once the fastening site is located, the fasteners employed must be truly able to securely maintain the tissue. Still further, the fastener must be readily deployable. Also, quite obviously, the fasteners are preferably deployable in the tissue in a manner which does not unduly traumatize the tissue.
Improved fasteners and systems for deploying the same are fully disclosed in copending application Ser. No. 11/043,903, filed Jan. 25, 2005, for SLITTED TISSUE FIXATION DEVICES AND ASSEMBLIES FOR DEPLOYING THE SAME, which application is incorporated herein by reference. The assembly includes a fastener including a first member, and a second member. The first and second members have first and second ends. The fastener further comprises a connecting member fixed to each of the first and second members intermediate the first and second ends and extends between and separates the first and second members. The first member has a longitudinal axis, a through channel along the axis, and a slit extending between the first and second ends and communicating with the through channel. A deployment wire or stylet is arranged to be slidingly received by the through channel of the first member and has a pointed tip to pierce into tissue. The stylet thus guides the fastener to the fastening location when a pusher pushes the first member into the tissue while on the deployment wire. As the first member is driven into the tissue by the pusher, the second member engages to tissue. This provides resistance against further movement of the fastener. Continued pushing of the fastener causes the first member to be deformed by the stylet. As the first member pivots on the connecting member, the stylet is forced out of the first member either by passing through the first member slit, the deformation of the first member, or a combination of these factors.
As can thus be appreciated, deployment of the fastener requires manipulation of both the pusher and stylet simultaneously. It would be desirable if the fastener deployment could be made easier by negating the need for the simultaneous manipulations. The present invention addresses this and other issues as will be seen subsequently.
The invention provides a fastener assembly for use in a mammalian body. The assembly comprises a fastener that fastens tissue, the fastener including a driven member that pierces tissue, and a stylet that guides the driven member into the tissue. The stylet includes an engagement structure that engages the driven member and imparts a translational force to the driven member that drives the driven member into the tissue.
The stylet may include a tissue piercing tip that pierces the tissue before the driven member engages the tissue. The driven member may be arranged to be released from the stylet by the engagement structure after being driven into the tissue.
The driven member may include a channel having an inner dimension, the stylet including a portion having a first outer dimension less than the inner dimension to enable the stylet to be received by the channel. The engagement structure may comprise an enlarged portion of the stylet having a second outer dimension greater than the inner dimension of the channel permitting the engagement structure to engage the driven member. The engagement structure may be spring loaded and take the form of a latch.
The driven member is arranged to be released from the stylet by the engagement structure after being driven into the tissue. The driven member may include a slit communicating with the channel and the driven member may be releasable from the stylet by the stylet passing through the slit. The fastener may further include a trailing member that engages the tissue after the driven member is driven into the tissue. The trailing member engaging the tissue holds the driven member while the engagement structure forces the stylet through the slit. The second outer dimension of the engagement structure may gradually increase to spread the driven member apart by widening the slit to facilitate the driven member being released from the stylet. The fastener may further include a connecting member that connects the driven member and trailing member together. The driven member and trailing member may each include a first end and a second end, and the connecting member may be connected intermediate the first and second ends of each of the driven member and trailing member.
The invention further provides a fastener assembly for use in a mammalian body. The assembly comprises a fastener including a driven member and a trailing member. The driven and trailing members have first and second ends. The fastener further includes a connecting member fixed to each of the driven and trailing members intermediate the first and second ends and extending between the first and second members. The driven and trailing members are separated by the connecting member. The driven member has a longitudinal axis, a through channel along the axis, and a slit extending between the first and second ends and communicating with the through channels. The assembly further comprises a stylet having a distal end and arranged for an interference fit within the through channel proximal the distal end to cause the stylet to pierce into the tissue, drive the driven member into the tissue and to be released from the driven member through the slit with a single distal movement of the stylet.
The driven member may include a web extending across the slit. The web is breakable by a predetermined force imparted to the web by the stylet.
The features of the present invention which are believed to be novel are set forth with particularity in the appended claims. The invention, together with further objects and advantages thereof, may best be understood by making reference to the following description taken in conjunction with the accompanying drawings, in the several figures of which like reference numerals identify like elements, and wherein:
The esophageal tract is controlled by an upper esophageal sphincter (UES)in the neck near the mouth for swallowing, and by the LES 48 and the GEFV 49 at the stomach. The normal anti-reflux barrier is primarily formed by the LES 48 and the GEFV 49 acting in concert to allow food and liquid to enter the stomach, and to considerably resist reflux of stomach contents into the esophagus 41 past the gastroesophageal tissue junction 52. Tissue aboral of the gastroesophageal tissue junction 52 is generally considered part of the stomach because the tissue protected from stomach acid by its own protective mechanisms. Tissue oral of the gastroesophageal junction 52 is generally considered part of the esophagus and it is not protected from injury by prolonged exposure to stomach acid. At the gastroesophageal junction 52, the juncture of the stomach and esophageal tissues form a zigzag line, which is sometimes referred to as the “Z-line.” For the purposes of these specifications, including the claims, “stomach” means the tissue aboral of the gastroesophageal junction 52.
The first member 102 is generally cylindrical or can have any other shape. It has a longitudinal axis 108 and a through channel 112 along the longitudinal axis 108.
The first member 102 also includes a first end 116 and a second end 118. Similarly, the second member 104 includes a first end 120 and a second end 122. The first end 116 of member 102 forms a pointed dilation tip 124. The dilation tip 124 may be conical and more particularly takes the shape of a truncated cone. The tip can also be shaped to have a cutting edge in order to reduce tissue resistance.
The first and second members 102 and 104 and the connecting member 106 may be formed of different materials and have different textures. These materials may include, for example, plastic materials such as polypropylene, polyethylene, polyglycolic acid, polyurethane, or a thermoplastic elastomer. The plastic materials may include a pigment contrasting with body tissue color to enable better visualization of the fastener during its deployment. Alternatively, the fastener may be formed of a malleable metal with shape memory, such as Nitinol.
As may be further noted in
It may be noted in
Referring now to
The first member 102 of the fastener 100 is slidingly received on the end of the deployment stylet 164. The deployment stylet 164 has a pointed tip 178 for piercing the tissue layers 180 and 182 to be fastened together. The stylet 164 has an enlarged engagement structure 166 proximal to the tip 178 having at least a portion with a cross-sectional dimension greater than that of the through channel for making an interference fit with through channel 112. This permits the stylet 164 to engage the member 102 and push the fastener member 102 through the tissue layers 180 and 182. It also serves to later separate or enlarge the slit 125 to release the stylet from the member 102 at the end of the deployment. The tissue piercing stylet 164, and the fastener 100 are both within the guide tube 168. The guide tube 168 may take the form of a catheter, for example, as previously mentioned, or a guide channel within a block of material.
As will be further noted in
With the first member 102 of the fastener 100 received on the tissue piercing stylet 164 and with the engagement structure 166 engaging the first member 102, the stylet may be translated in a distal direction towards the tissue to cause the tip 178 of the tissue piercing stylet 164 to pierce the tissue layers 180 and 182. The tissue piercing stylet 164 and fastener 100 are guided to the tissue layers 180 and 182 by the guide tube 168.
As shown in
As will be still further noted in
Eventually, with further continued forward movement of stylet 164, the slit 125 becomes wide enough to permit the stylet 164 to be released from the member 102 and more particularly, the through channel 112, through the enlarged slit 125.
The deployment and release of the fastener 100 from the stylet 164 is made possible with but a single forward stroke of the stylet. This minimizes the number of elements which must be manipulated or controlled during deployment of the fastener 100.
In
The first member 102 of the fastener 100 is slidingly received on the deployment stylet 564. The pointed tip 578 of the stylet 564 is piercing the tissue layers 180 and 182. The stylet 564 has an engagement structure proximal to the tip 578 taking the form and function of a spring loaded latch 570 having spring loaded wings 572 and 574. When forced outwardly by a spring (not shown) internal to the stylet 564, the wings 572 and 574 present a cross-sectional dimension greater than that of the through channel 112 of the fastener 100 (
As previously described with respect to the embodiment of
It will be noted that the fastener 100 has returned to its original shape. The tissue layers 180 and 182 are fastened together between the first and second members 102 and 104 of the fastener 100.
The deployment and release of the fastener 100 from the stylet 164 is made possible with but a single forward stroke of the stylet. The next fastener 100A may now be advanced over the spring loaded latch into a loaded position for engagement by the latch. When the fastener 100A passes over the latch 570, the wings 572 and 574 will retract into the body of the stylet against the spring force. When the fastener reaches its loaded position, the wings 572 and 574 snap out to engage the fastener. Fastener 100A is then ready to be deployed.
As will be appreciated by those skilled in the art, the wings 572 and 574 of the spring loaded latch may be alternatively formed of resilient wire. The proximal ends of the wires would be welded to the stylet. The wire may be configured to take an unstressed shape corresponding to the shape of the wings 572 and 574. This would negate the need for providing a spring or springs within the body of the stylet.
A further embodiment of a stylet having a spring loaded latch is shown in
While the invention has been described by means of specific embodiments and applications thereof, it is understood that numerous modifications and variations may be made thereto by those skilled in the art without departing from the spirit and scope of the invention. It is therefore to be understood that within the scope of the claims, the invention may be practiced otherwise than as specifically described herein.
This application is related to U.S. patent application Ser. No. ______ (Atty. Docket No. 2234-13-3) entitled “TISSUE FIXATION ASSEMBLIES HAVING A PLURALITY OF FASTENERS READY FOR SERIAL DEPLOYMENT”, which was filed on the same day as the present application and which is incorporated by reference.